BOC Sciences grandly announced the schedule of a free webinar on September 19th, 2022, at 11:00 EDT, which is a laudable event centering on the hot spot of RNA research during the pandemic.
BOC Sciences is an expert in RNA technologies. It is now renowned as the largest manufacturer of pseudoUridine and its derivatives, the critical materials for RNA modification. BOC Sciences' annual production capacity of pseudoUridines and N1-MethylpseudoUridines exceeds 500 kg and 1,000kg respectively, confirming its well-deserved top position among competitors.
September 19th, 11:00 EDT, BOC Sciences will join hands with Dr. David Courtney from Queen's University Belfast, School of Medicine, Dentistry and Biomedical Sciences and introduce the blockbuster webinar: Viral RNA Modifications and Implications for Novel Therapeutics.
Since Dr. David and his lab have specialized in research on influenza viruses for several years, they obtain very fruitful findings to be shared in the webinar. In particular, Dr. David would like to present his insightful ideas about the role of RNA modifications in viral replication, specifically the influenza A virus, and how it might inform the design of both novel antivirals and mRNA-based therapeutics. This webinar will undoubtedly bring enlightenment to the research peers or industrial decision-makers who are involved in the R&D of RNA therapeutics.
BOC Sciences and Dr.David summarized 4 highlights of the upcoming webinar:
- Identify which RNA modifications are important for viral replication
- Reveal how m6A affects influenza virus replication
- Discuss how viral RNAs are modified
- Present how RNA modifications might inform future therapeutics
All above are to be addressed within the 1-hour online meeting while a brief Q&A session will follow to clear the doubts of listeners regarding the presentation. Anyone interested in this topic, whether they are students, researchers, managers, etc., are welcome to participate. It's completely free since BOC Sciences, with a strong sense of social responsibility, holds the vision to enhance communication and inspire innovation via a series of meaningful events.
BOC Sciences opened the registration channel online a few days ago. The audience can register at https://www.bocsci.com/webinar-viral-rna-modifications-and-implications-for-novel-therapeutics.html. Just fill in the required fields of Name, Email, Phone, Organization, and Job Title. Then wait for the notification email where a link to the zoom meeting will be sent. BOC Sciences' IT team has made much effort to simplify the procedures and save time for registrants.
“All preparatory work has been accomplished. And now we are expecting your attendance to broaden our scientific community,” the business development manager of BOC Sciences sincerely sent out invitations.
About
BOC Sciences has been engaged in RNA-related research and development for years. It produces guaranteed pseudoUridines and derivatives for both academic institutions and pharmaceutical companies, playing a crucial role in the global combat against COVID-19, especially in the creation of efficient mRNA vaccines.
